4 Funding Announcements Made By Payer/Employer Health Tech Startups in March
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced this month.
Here is a list of some of the biggest funding rounds in the payer/employer space that were announced this month.
Insurers should immediately end their overreach into medical decision-making and work with medical providers and their patients to ensure timely care for all.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
A new report from Ernst & Young revealed that healthcare organizations are seeing financial benefits and improved outcomes from their health equity strategies.
Given the increasing competition and rising back-office costs, embracing AI-powered revenue cycle automation to boost profitability and achieve operational excellence is more crucial than ever.
Labcorp is buying the clinical diagnostics and reproductive women’s health businesses of BioReference Health, excluding those assets in New York and New Jersey. Labcorp has returned to being fully focused on lab testing after last year’s spinoff of Fortrea, its former clinical trial services business.
A healthy and inclusive workplace environment needs flexible solutions that are personalized to all lifestyles, work schedules, cultures and food preferences.
The conference will be held at the Ritz Carlton hotel in Chicago May 21-22. Space is limited., so secure your spot today to attend!
Here is a list of some of the most notable funding round announcements that took place this March in the provider technology space.
One year after the Medicaid continuous enrollment provision ended, 19.2 million people have been disenrolled from Medicaid, according to KFF. This is higher than many expected, and experts have mixed reviews on how they think this process has gone.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The lack of adoption of interoperability tools by healthcare providers is a complex issue that requires a multi-faceted approach
Cancer drug developer Boundless Bio is a pioneer in therapies that target extrachromosomal DNA. The IPO cash will support its pipeline, including a lead program on track to report preliminary data later this year.
This technology can result in reduced readmission rates, increased patient satisfaction, and a consistent flow of post-acute care revenue, especially in rural areas.
At HIMSS24, Heather O'Sullivan, Mass General Brigham's president of healthcare at home, said that the health system wants to move 10% of all its medical patients to the home. She argued that there is "no greater model of care for being patient-centric," and highlighted the care modality's ability to alleviate burnout for some healthcare workers.
Through a new partnership, FOLX members can gain access to crisis counselors through Crisis Text Line in addition to their support from the FOLX Health care team.